Genewise Bio

Company Deals Medical Device

BOE-Backed Genewise Bio Secures RMB 100 Million in Series A Financing for Molecular Diagnostics

Fineline Cube Jun 5, 2024

Genewise Bio, a molecular diagnostics company nurtured by BOE Technology Group, has reportedly secured RMB...

Company Drug

Clover Bio Reports Positive SCB‑1019 Phase I Data – RSV PreF Vaccine Demonstrates Superior Booster Response vs. GSK’s Arexvy

Company

Merck KGaA Inaugurates China R&D Center – Beijing BioPark Hub Targets First‑Tier Global Drug Launch Status

Company

Atom Therapeutics Files Hong Kong IPO – URAT1 Inhibitor ABP-671 Targets First‑Line Gout Treatment Market

Company Deals

Asieris Pharma Partners with SPH Keyuan to Commercialize Cevira – World’s First Non‑Surgical Cervical Precancer Treatment Launches in China